Cardiovascular disease among patients with type 2 diabetes: Role of homocysteine as an inflammatory marker
Saved in:
| Date: | 2016 |
|---|---|
| Main Authors: | A. Sahu, T. Gupta, A. Kavishwar, R. K. Singh |
| Format: | Article |
| Language: | English |
| Published: |
2016
|
| Series: | The Ukrainian Biochemical Journal |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000567442 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Glycemic control in prevention of cardiovascular diseases in diabetes mellitus
by: A. N. Korzh
Published: (2019)
by: A. N. Korzh
Published: (2019)
Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Content resistin plasma and nonspecific inflammation markers in patients with type 2 diabetes compensation from different diseases
by: A. M. Urbanovych
Published: (2015)
by: A. M. Urbanovych
Published: (2015)
The role of apelin in the pathogenesis of cardiovascular and gastrointestinal diseases
by: V. P. Sinelnik
Published: (2015)
by: V. P. Sinelnik
Published: (2015)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
The problem of adherence to long-term treatment of patients with cardiovascular diseases
by: E. A. Naumova, et al.
Published: (2014)
by: E. A. Naumova, et al.
Published: (2014)
Women’s Health and Cardiovascular Diseases
Published: (2012)
Published: (2012)
Women’s Health and Cardiovascular Diseases
Published: (2012)
Published: (2012)
The role of the interaction of risk factors in the formation of the probability of fatal outcome of cardiovascular diseases
by: E. A. Jakimenko, et al.
Published: (2016)
by: E. A. Jakimenko, et al.
Published: (2016)
Identification of genes involved in cardiovascular diseases
by: D. Abdusa
Published: (2016)
by: D. Abdusa
Published: (2016)
Prospects of gene therapy for the treatment of cardiovascular diseases
by: A. K. Gulevskij, et al.
Published: (2012)
by: A. K. Gulevskij, et al.
Published: (2012)
The state of the pro-inflammatory cytokine level in patients with unstable angina and type 2 diabetes mellitus depending on functional class of chronic heart failure
by: A. N. Belovol, et al.
Published: (2013)
by: A. N. Belovol, et al.
Published: (2013)
The role of apoptosis in the combined course of chronic obstructive pulmonary disease and type 2 diabetes mellitus
by: N. K. Sukhonos
Published: (2017)
by: N. K. Sukhonos
Published: (2017)
Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer
by: Tastekin, D., et al.
Published: (2015)
by: Tastekin, D., et al.
Published: (2015)
Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer
by: D. Tastekin, et al.
Published: (2015)
by: D. Tastekin, et al.
Published: (2015)
D-dimer as a potential predictor of thromboembolic and cardiovascular complications in patients with chronic kidney disease
by: I. S. Mykhaloiko, et al.
Published: (2020)
by: I. S. Mykhaloiko, et al.
Published: (2020)
Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
by: Tovazhnyanska, E.L., et al.
Published: (2014)
by: Tovazhnyanska, E.L., et al.
Published: (2014)
The role of connexin 37 gene polymorphism (1019C > T; Pro319Ser) in cardiovascular disease
by: Pitha, J., et al.
Published: (2011)
by: Pitha, J., et al.
Published: (2011)
Role of Probiotics in the Prevention and Management of Cardiovascular Diseases: Insights from a Doxorubicin-Induced Model
by: Starovoitova, S.O., et al.
Published: (2025)
by: Starovoitova, S.O., et al.
Published: (2025)
Echographic markers of vascular and cardiac disorders in patients with arterial hypertension and arterial hypertension associated with type 2 diabetes mellitus
by: Ya. K. Radzishevska
Published: (2015)
by: Ya. K. Radzishevska
Published: (2015)
Evaluation of Interleukins and Biochemical Markers Levels Among COVID-19 Iraqi Patients
by: Al-Jubury, Kutaiba Sattar, et al.
Published: (2025)
by: Al-Jubury, Kutaiba Sattar, et al.
Published: (2025)
Cytogenetic features of cervical epithelium at inflammatory diseases
by: O. I. Aleksieienko
Published: (2011)
by: O. I. Aleksieienko
Published: (2011)
Effect of cryopreserved placental mesenchymal stromal cells on pro-inflammatory state in experimental type 2 Diabetes mellitus
by: Ju. A. Demin, et al.
Published: (2015)
by: Ju. A. Demin, et al.
Published: (2015)
Endothelium and endothelial dysfunction - health implications and risk for cardiovascular diseases
by: Rutowski, J.A., et al.
Published: (2012)
by: Rutowski, J.A., et al.
Published: (2012)
Development of effective anti-inflammatory drug candidates among novel thiazolopyridines
by: T. I. Chaban, et al.
Published: (2020)
by: T. I. Chaban, et al.
Published: (2020)
Vitamin D in the complex treatment of diabetes type 2 patients
by: A. S. Yefimov, et al.
Published: (2014)
by: A. S. Yefimov, et al.
Published: (2014)
Current therapeutic aspects of female genital inflammatory diseases
by: Ju. Kuzmina
Published: (2008)
by: Ju. Kuzmina
Published: (2008)
Premature aging indices in patients with moderate cardiovascular risk
by: Ye. Zaprovalna, et al.
Published: (2021)
by: Ye. Zaprovalna, et al.
Published: (2021)
The blood leptin content and the activity of the zonal system response in patients with diabetes mellitus type 2 with different body weight and disease duration
by: B. M. Mankovskyi, et al.
Published: (2014)
by: B. M. Mankovskyi, et al.
Published: (2014)
Capabilities of pharmacotherapy for vascular rigidity in patients with cardiovascular pathology
by: E. A. Melnikova, et al.
Published: (2018)
by: E. A. Melnikova, et al.
Published: (2018)
The content of pro-inflammatory cytokines IL-1β, IL-6, IL-17A and TNFα in the blood of patients with type 2 diabetes after therapy with metformin
by: K. P. Zak, et al.
Published: (2020)
by: K. P. Zak, et al.
Published: (2020)
Prospects for the use of umbilical cord blood in the treatment of diseases of the cardiovascular system
by: I. Y. Shchenyavskyi
Published: (2023)
by: I. Y. Shchenyavskyi
Published: (2023)
Complex treatment of acute pelvic inflammatory disease in women of reproductive age with chronic diseases of hepatobiliary system
by: S. R. Galich, et al.
Published: (2014)
by: S. R. Galich, et al.
Published: (2014)
Use of Low Temperature Factor in Treatment of Inflammatory Diseases of Otorhinolaryngology Organs
by: A. S. Zhuravlev, et al.
Published: (2012)
by: A. S. Zhuravlev, et al.
Published: (2012)
Pro-inflammatory cytokines and psychoneurological sings in cancer patients
by: N. E. Prokhach, et al.
Published: (2013)
by: N. E. Prokhach, et al.
Published: (2013)
Specificity of perception and emotions in patients with schizophrenia with diabetes mellitus type 2
by: Ye. V. Opria
Published: (2018)
by: Ye. V. Opria
Published: (2018)
Similar Items
-
Glycemic control in prevention of cardiovascular diseases in diabetes mellitus
by: A. N. Korzh
Published: (2019) -
Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021) -
Content resistin plasma and nonspecific inflammation markers in patients with type 2 diabetes compensation from different diseases
by: A. M. Urbanovych
Published: (2015)